Rachad Zayat: Acute PE Study Finds USAT Associated With Better In-Hospital Outcomes
Rachad Zayat, Consultant Cardiac Surgeon at RWTH University Hospital Aachen, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Thoracic Disease, adding:
“Excited to share our latest publication!
Ultrasound-facilitated catheter-directed thrombolysis is associated with improved survival and reduces hospital stay in acute pulmonary embolism: a propensity score-matched analysis.
Published in Journal of Thoracic Disease.
Key Findings:
In a propensity score-matched analysis of 162 patients with acute pulmonary embolism (PE) treated within a multidisciplinary PERT team:
- USAT (EKOS) was associated with significantly lower in-hospital mortality (2.5 percent versus 17.3 percent)
- Shorter hospital stay (13 versus 17.5 days)
- Fewer major bleeding events (1.2 percent versus 11.1 percent)
USAT appears to be a safe and effective option for intermediate-high and high-risk PE patients.”
Title: Ultrasound-facilitated catheter-directed thrombolysis is associated with improved survival and reduces hospital stay in acute pulmonary embolism: a propensity score-matched analysis
Authors: Ahmad G. M. N. Abdelsamad, Rashad Zayat, Yusuf Shieba, Alexander Kersten, Nikolaus Marx, Michael Dreher, Nima Hatam, Sebastian Kalverkamp, Jan Spillner

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 6, 2026, 13:28Inna Vilshanivska: Sharing Ukraine’s Experience in Blood Donor Retention at the ISBT 2026
-
Jul 6, 2026, 13:10Arun V. J.: Did You Know A Glass Of Water is The Best Way To Retain A Blood Donor?
-
Jul 6, 2026, 13:10Javed Anees: The Hidden Power of Biotin in Modern Medicine
-
Jul 6, 2026, 12:46Saneha Anjum Shaikh: Red Cell Aliquoting – Precision in Transfusion Medicine
-
Jul 6, 2026, 12:43Jennifer Dumont: WFH 2026 Congress Highlights – Expert Insights on Hemophilia Care
-
Jul 6, 2026, 12:39Muhammad Hamza: Can Hemolysis Affect Laboratory Results?
-
Jul 6, 2026, 12:32Syed A. Rizvi: Natural Blood Thinners – What Does the Science Really Say
-
Jul 6, 2026, 12:27Abdul Mannan: Perioperative Bridging of Warfarin Patients Is a Risk-Based Decision
-
Jul 6, 2026, 12:20Wolfgang Miesbach: ISTH 2026 Marks a New Era in Immune Thrombocytopenia Management